Eli Lilly Sola Failure is a 'Serious Blow' to Biogen (BIIB) and Others in AD Field - Leerink
Go back to Eli Lilly Sola Failure is a 'Serious Blow' to Biogen (BIIB) and Others in AD Field - Leerink| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 227.53 +2.17 (0.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $225.36 | 52 Week High | $333.65 | |||
| Open | $226.94 | 52 Week Low | $223.02 | |||
| Day High | $229.19 | P/E | 29.13 | |||
| Day Low | $222.36 | EPS | $7.81 | |||
| Volume | 1,494,461 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1150.99 -19.15 (1.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1170.14 | 52 Week High | $88.16 | |||
| Open | $1174.71 | 52 Week Low | $67.88 | |||
| Day High | $1188.88 | P/E | 266.43 | |||
| Day Low | $1145.98 | EPS | $4.32 | |||
| Volume | 2,155,791 | |||||
